Serious ocular complications of zoledronate.
Woo
T C S
TC
Department of Radiation Oncology, Sir Charles Gairdner Hospital, Western Australia, Australia.
Joseph
D J
DJ
Wilkinson
R
R
D000368:Aged; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D003231:Conjunctivitis / Q000139:chemically induced*; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D014606:Uveitis, Anterior / Q000139:chemically induced; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid